People

Rohan Palekar

Biotechnology executive and chairman of Newleos Therapeutics, also serving on Neurogene's board. Previously chief executive officer at 89bio from June 2018 to January 2026, with earlier leadership at Avanir, Medivation and Johnson & Johnson. Holds a Dartmouth MBA and Mumbai commerce and law degrees.